Prolactinoma and Acromegaly 2 (posters)

MON-0703

Evaluation of the Effetcs of Octreoide and Lanreotide on Growth Hormone and Adenoma Size in Acromegalic Patients
Fusun Salgur, Pelin Tutuncuoglu, Mithat Bahceci, Ahmet Gorgel, Hüsnü Yilmaz and Gonca Oruk

MON-0705

A Low Dose of GH Alters Cell Signaling and Growth in Human Metastatic Melanoma Cell Lines
Elahu Gosney Sustarsic, Riia Karoliina Sustarsic, James Herpy, Martin Bidlingmaier and John J Kopchick

MON-0706

Giant Prolactinomas: Clinical Manifestations and Outcomes of 16 Arab Cases
Mussa H Almalki, Naji J Aljohani, Saad H Alzahrani, Safia M Sherbeeni, Badurudeen M Buhary and Ghada Alhowsawi

MON-0708

Recurrence of Hyperprolactinemia after Discontinuation of Dopamine Agonist Therapy in Patients with Prolactinomas
Carolina Ballarino, Sabrina Diez, Susana Mallea Gil, Mariana Salazar and Graciela Stalldecker

MON-0709

Prolactinoma in Pregnancy – Macroprolactinomas, Always a Surprise?
Alice Helena Violante, Adilson Lamounier Jr., Erika Cesar de Oliveira Naliato, Fernanda Dias Carneiro Carneiro and Renan Moritz Almeida

MON-0710

Epicardial Adipose Tissue Thickness in Patients with Prolactinoma
Dilek Yazici, Murat Sunbul, Mehmet Yasar, Oguzhan Deyneli and Dilek Yavuz

MON-0712

Determinants of Recurrent Hyperprolactinemia in Prolactinomas and Idiopatic Hyperprolactinemia after Dopamine Agonists Suspension
Eva Lau, Joana Isabel Oliveira, Ana Isabel Oliveira, Paula Freitas, Eduardo Vinha and Davide Carvalho

MON-0713

Characterization of Presentation and Treatment Patterns of Prolactinomas in Male and Female Patients
Arpeta Gupta, Michael D. Richter, Faisal Kamal, Kalmon D. Post and Eliza B. Geer

MON-0714

Immunohistochemistry Is NOT Predictive of Response to Cabergoline in Clinically Nonfunctioning Pituitary Adenomas
Rafael Loch Batista, Nina de Castro Musolino, Clarissa Groberio Borba, Valter Angelo Sperling Cescato and Malebranche Cunha Neto

MON-0715

Study Design of a Phase II Trial of Subcutaneous Pasireotide Alone or Combined with Cabergoline in Patients with Cushing's Disease
Maria Fleseriu, Rosario Pivonello, Alberto M Pedroncelli, Heather Patino, Moncy Ye, Mounir Aout and Richard A. Feelders

MON-0717

Clinical Features of GH and TSH Co-Secreting Pituitary Adenoma
Noriaki Fukuhara, Hiroshi Nishioka and Shozo Yamada

MON-0719

Young Female with Acromegaloid Features, Pituitary Macroadenoma and an Uncomplicated Pregnancy
Carlos Rafael Figueroa, Jose Hernan Martinez, Monica Santiago, Coromoto Palermo, Michelle M Mangual, Rafael Trinidad, Madeleine Gutierrez, Alfredo Sanchez, Maria de Lourdes Miranda and Eva Gonzalez

MON-0720

Personality Traits in Acromegalic Patients: Comparison with Patients with Non-Functioning Adenomas and Healthy Controls
Aysegul Atmaca, Elif Kilic Kan, Gokhan Sarisoy, Feyzi Gokosmanoglu and Gulcin Cengiz Ecemis

MON-0722

Association Between ACE and AGT Polymorphism and Cardiovascular Risk in Acromegalic Patients
Tomris Erbas, Nese Cinar, Selcuk Dagdelen, Arzu Gedik, Hikmet Yorgun, Ugur Canpolat and Giray Kabakci

MON-0723

Pre-Surgical Medical Treatment Improve the Remission Rate in Acromegaly
Henry Dufour, Thierry Brue, Frederic Castinetti, Isabelle Morange, Frederique Albarel and Thomas Graillon

MON-0724

Characteristics of Acromegalic Patients By Generation
Shingo Fujio, Yuki Kasamo, Mika Habu, Syunji Yunoue, Hirofumi Hirano, Hiroshi Tokimura, Hiroshi Arimura, Yoshihiko Nishio and Kazunori Arita

MON-0725

Safety of Long-Term (up to six years) Treatment with Pegvisomant: Analysis of Spanish Patients Included in Global Acrostudy
Ignacio Bernabeu, Eva Venegas, Tomás Lucas, Cristina Alvarez -Escola, Juan Antonio Garcia-Arnés, Mónica Marazuela, Peter J. Jonsson, Nuria Mir, Roy Gomez, Spanish Acrostudy Group and Antonio Pico

MON-0727

Acromegaly Treatment Patterns in a Large US Managed Care Health Plan
Tanya Burton, Laura Becker, Elisabeth LeNestour, Maureen P Neary and William H Ludlam

MON-0728

Sagit©: A Novel Comprehensive Clinical Practice Tool for Managing Acromegaly
Andrea Giustina, John S Bevan, Marcello D Bronstein, Felipe F Casanueva, Philippe Chanson, Stephan Petersenn, Xuan-Mai Truong Thanh, Christine Massien, Carla Dias-Barbosa, Isabelle Guillemin, Benoit Arnould and Shlomo Melmed

MON-0729

Biochemical Remission of Acromegaly after Withdrawal of Drug Treatment: Preliminary Data from a Large Prospective Multicentric Study
Alessandra Casagrande, Debora Maria Nazato, Marcello D Bronstein, Raquel S Jallad, Mônica Gadelha, Nelma Veronica Marques, Aline Barbosa Moraes, Mauro Antonio Czepielewski, Artur Boschi, Lucio Vilar, Paula C. L. Elias, Margaret De Castro, Antonio Ribeiro Oliveira Junior, Junia Schweizer, Estela Muszkat Jatene, Miriam da Costa Oliveira, Carolina G.S. Leaes, Cesar Luiz Boguszewski, Jose Italo Soares Mota, Paulo Augusto Miranda and Julio Abucham

MON-0730

Assessment of the Microcirculation in Vivo with Nailfold Videocapillaroscopy in Acromegaly
Selcuk Dagdelen, Safak Akin, Levent Kilic, Ali Akdogan and Tomris Erbas

MON-0731

Symptoms and Sign of Active Acromegaly in Patients from Moscow Region
Alexander V Dreval, Yulia G Pokramovich, Olga Nechaeva, Tatyana Shestakova, Irina V Trigolosova and Irena A Ilovayskaya

MON-0733

MON-0734

Pegvisomant (PEGV; Somavert®) Safety in Acromegaly: Analysis of Data from the Pegv Integrated Clinical Trial Safety Database (ICTSD)
Natasa Rajicic, Judith Hey-Hadavi, Nina Camacho-Hubner, Nicky Kelepouris, Roy Gomez, Joseph F. Heissler and Jose Francisco Cara

MON-0735

Acromegalic Arthropathy Assessed By 3.0 Tesla Magnetic Resonance Imaging (MRI): A Case-Control Study
Kim M.J.A. Claessen, Paul W de Bruin, Willemien Visser, Badelog JE de Lange-Brokaar, Alberto M. Pereira, Herman Kroon, Margreet Kloppenburg and Nienke R. Biermasz

MON-0736

Autonomic Disfunction and Cardiac Alterations in Acromegalic Patients with Obstructive Sleep Apnoea Syndrome: Preliminary Data
Maria Vittoria Davi', Francesca Dal Molin, Luigi Fondrieschi, Mattia Cominacini, Simone Romano, Cinzia Castellani, Marcello Ferrari, Luca Dalle Carbonare and Giuseppe Francia

MON-0737

Acromegaly in Sweden 1991-2011: Prospective Study Based on the Swedish Pituitary Registry
Steinunn Arnardottir, Pia Burman, Per Dahlqvist, Bertil Ekman, Charlotte Höybye, Jacob Järås, Thord P Rosen and Britt Eden Engström

MON-0738

Growth Hormone Receptor Deletion of Exon 3 and the Outcome of Long-Acting Somatostatin Analogues in Combination with Pegvisomant in 104 Acromegaly Patients, with Follow up for up to 9 Years
Sanne Franck, Aart J. van der Lely, Richard A. Feelders, Joseph A M J L Janssen, Jens Otto Jorgensen and Sebastian J.C.M.M. Neggers

MON-0739

Significant Differences in Estrogen, Dopamine 2 and Somatostatin Receptors Expression Profile Between Clinically Non-Functioning Adenomas and Acromegaly
Filip Gabalec, Monika Drastikova, David Netuka, Vaclav Masopust, Tomas Cesak, Josef Machac, Josef Marek, Martin Beranek and Jan Cap

MON-0740

Serum IGF-1 and FGFR4 Genetic Status in the Risk of Benign and Malignant Neoplasms in Acromegaly
Sonia Cheng-Oviedo, Karen Gomez-Hernandez, Omar Serri, Constance L Chik and Shereen Z Ezzat